Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
OCGN · against 273 other Healthcare companies of similar size
Ranked #121 of 274 · scores higher than 55% of peers
Bars: peers in each 10-point band of the growth score24 peers with a growth score of 50–59, including OCGN · Click a bar to see the companies
A mix: stronger 3-year revenue growth, but weaker earnings per share growth and revenue growth than most Healthcare peers.
| Metric | OCGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 288 reported | -3.6% | 3.4% | 31% | 33% | |
| Earnings per share growthHigher is better · 122 reported | Not reported | 2.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 266 reported | 26.3% | 4.0% | 85% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 2 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 2 | 592M ILS (≈$160M) | 99 | 84 | |
| 2 | 433M USD | 99 | 81 | |
| 116 | 334M USD | 51 | 53 | |
| 116 | 3.4B SEK (≈$337M) | 51 | 45 | |
| 121 | 2.9B HKD (≈$366M) | 50 | 47 | |
| 121 | 55.7B JPY (≈$379M) | 50 | 64 | |
| 121 | 253M USD | 50 | 15 | |
| 124 | 406.2B KRW (≈$292M) | 49 | 51 | |
| 125 | 2.7B CNY (≈$384M) | 48 | 65 | |
| 125 | 201M USD | 48 | 24 | |
| 125 | 19.8B INR (≈$238M) | 48 | 37 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score